MDC Ventures (formerly KBS Ventures)

Israel
Firm Location:Israel • Germany • Barcelona, Spain • Netherlands • Bonn, Germany
Investor Firms That Co-Invest with MDC Ventures (formerly KBS Ventures)
MDC Ventures (formerly KBS Ventures) Team
Photo of Bauke Anninga, MDC Ventures (formerly KBS Ventures)
Bauke Anninga
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London, Investors in Netherlands
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in London (Other Lists)
Photo of Nadiya Ishnazarova, Principal at MDC Ventures (formerly KBS Ventures)
Nadiya Ishnazarova
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Sarah Luppino, Principal at MDC Ventures (formerly KBS Ventures)
Sarah Luppino
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Barcelona (Spain)
Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Semiconductors (Series B), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed)
Photo of Sebastian Schöfer, Managing Director at MDC Ventures (formerly KBS Ventures)
Sebastian Schöfer
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Bonn (Germany)
Photo of Christian Uhrich, Managing Director at MDC Ventures (formerly KBS Ventures)
Christian Uhrich
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Noga Yerushalmi, Investor at MDC Ventures (formerly KBS Ventures)
Noga Yerushalmi
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Israel
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B)